Contract 75A50124C00003
Mapp Biopharmaceutical, Inc. · Department Of Health And Human Services · August 13, 2024
Mapp Biopharmaceutical, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on August 13, 2024 for $3.00 million (current value) of work in research and development in biotechnology (except nanobiotechnology). Performance is in San Diego, CA. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses cost-plus contract pricing. The most recent modification was on June 24, 2025. If all options are exercised, the contract could reach $38.24 million.
Contract details
- PIID
- 75A50124C00003
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- General Science And Technology R&D Services; General Science And Technology; Basic Research
- Place of performance
- San Diego, CA
- First action
- August 13, 2024
- Latest action
- June 24, 2025
Description
THE PURPOSE OF THE UNILATERAL NO COST MODIFICATION IS TO DESIGNATE THE ALTERNATE COR DR. SAIMA ZAMAN AS THE PRIMARY COR IAW THE EXECUTED COR DESIGNATION MEMORANDUM. DR. CAROL DIAZ-DIAZ WILL ASSUME THE POSITION OF ALTERNATE COR.
Modification timeline
-
June 24, 2025Mod P00010 · Other Administrative Action$3.00M
-
August 13, 2024Mod P00001 · Other Administrative ActionNO COST MODIFICATION TO REVISE INDIRECT RATES IN SECTION G.7.$2.96M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50124C00003?
Contract 75A50124C00003 is a federal contract awarded to Mapp Biopharmaceutical, Inc. by Department Of Health And Human Services on August 13, 2024 for $3.00 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 75A50124C00003?
Mapp Biopharmaceutical, Inc. won contract 75A50124C00003 from Department Of Health And Human Services.
How much is contract 75A50124C00003 worth?
Contract 75A50124C00003 has obligated $0 to date but carries a potential ceiling of $38.24 million if fully funded and all options are exercised.